Evidence map›Paper›PMID 28968824›Full record

ArticleThe Journal of infectious diseases2017

Regional Challenges in the Prevention of Human Immunodeficiency Virus Drug Resistance.

Catherine Godfrey, Marina Bobkova, Charles Boucher, Giovanni Ravasi, Ping Chen, Fujie Zhang, Yasong Wu, Rami Kantor

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Catherine GodfreyDivision of AIDS, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH).
Marina BobkovaIvanovsky Institute of Virology, Russia.
Charles BoucherErasmus Medical Center, Department of Viroscience, The Netherlands.
Giovanni RavasiPan American Health Organization/World Health Organization.
Ping ChenChina Office, Office of Global Research, NIAID, NIH.
Fujie ZhangClinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University.
Yasong WuDivision of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Rami KantorDivision of Infectious Diseases, Department of Medicine, Brown University Alpert Medical School.

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH · 1998 to 2026
$51.7M
Optimizing HIV Treatment Monitoring under Resource ConstraintsR01AI108441 · NIAID · BROWN UNIVERSITY · PI HOGAN, JOSEPH W, KANTOR, RAMI · 2015 to 2019
$3.5M
NIAID NIH HHS P30 AI042853NIAID NIH HHS R01 AI108441World Health Organization 001
6 · The paper itself

Abstract

In diverse global regions with significant human immunodeficiency virus (HIV) burden, programmatic, cultural, and provider-, patient-, and virus-related factors may result in HIV drug resistance, with global implications. This article reviews such common and unique challenges in Russia, Latin America and the Caribbean, China, and India, to suggest potential solutions.

Indexed as

Anti-HIV AgentsCaribbean RegionChinaDeveloping CountriesDrug Resistance, ViralHIVHIV InfectionsHumansIndiaLatin AmericaRussiaViral LoadAnti-HIV AgentsChinaHIV drug resistanceIndiaLatin AmericaRussia

Identifiers

PMID28968824
PMCPMC5853282

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.